COVID-19 and senior care will be topic of March 25 webinar
Mar 18, 2020
Learn evidence-based ways to protect residents from serious harm that can come from the novel coronavirus at a free webinar on Wednesday, March 25.
Feds stepping up efforts to make coronavirus tests available
By
Alicia Lasek
Mar 09, 2020
Millions of COVID-19 diagnostic tests will become available this week, according to the White House and federal health agencies.
Genesis HealthCare looks toward pandemic recovery after CEO change
By
Danielle Brown
Jan 06, 2021
The new chief executive officer of post-acute care giant Genesis HealthCare is hoping to steer the company onto a steadier path after months of financial uncertainty caused by the pandemic.
Free LTC infection prevention tool from Yale aims to help nursing home staff save time
By
Alicia Lasek
Nov 09, 2021
A one-stop set of infection prevention resources is meant to make work a bit easier for direct care providers, administrators, managers and support staff, say the Yale School of Nursing and the New York...
Senators want list of infected nursing homes made public
By
Danielle Brown
Apr 06, 2020
Facilities with one or more coronavirus infections should be identified publicly, a pair of federal lawmakers assert in a letter to the leaders of CMS and the CDC.
Alzheimer’s blood test to be used in memory-loss prevention trial
By
Alicia Lasek
Nov 12, 2021
The PrecivityAD blood test will lower barriers to participation in a new clinical trial that aims to prevent the symptoms of Alzheimer’s disease, researchers say.
Healthcare workers first in line for newly approved at-home coronavirus test
By
Alicia Lasek
Apr 21, 2020
Care providers are asked to complete a short eligibility assessment before ordering the FDA-authorized test kit. Self-swabs are mailed back for testing.
Court: Medicare hospice provider cap calculated improperly
Mar 04, 2010
The federal Medicare hospice provider cap is calculated in a way that is “arbitrary, capricious, an abuse of discretion, and unlawful,” a federal court recently ruled.
FDA advisers object to Alzheimer’s drug aducanumab ahead of final decision
By
Alicia Lasek
Apr 05, 2021
The experimental Alzheimer’s drug aducanumab is not ready for federal approval in June, advisers to the Food and Drug Administration say in a new JAMA editorial.
Coronavirus cases skyrocket by 60% in Texas nursing homes
By
Danielle Brown
Jul 20, 2020
COVID-19 cases are spreading rapidly throughout Texas nursing homes, recent state figures show. The number of nursing home residents in the state who have tested positive for the coronavirus has...